Development of a Pathologist Scoring Method to Determine Inflamed, Excluded or Desert Immune Phenotype in Carcinoma

Home > Science Hub > Development of a Pathologist Scoring Method to Determine Inflamed, Excluded or Desert Immune Phenotype in Carcinoma
Back to the list

March 5, 2025

Pierre Gontard, Koen Marien, Konstantinos Avraam, Paula Lopez-Arias, Yannick Waumans, Nicholas Dupuis, Elizabeth Ross, Mark Kockx

You might also be interested by

Brochures & Infographics

Immunohistochemistry (IHC) Biomarker List

August 10, 2026

Histopathology

More info

Videos

Poster Video: Induction of an effective immune response is an essential element of cancer immunotherapy

September 2, 2025

Histopathology

More info

Scientific Publications

Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer

January 27, 2025

Histopathology

More info

Posters

Development of a visual scoring method to determine inflamed, excluded or desert immune phenotype in Non-Small Cell Lung Cancer, Colorectal Cancer, and Urothelial Cancer

November 7, 2024

Histopathology

More info